There are no vaccines to prevent malaria. It is a disease that threatens nearly half of the world’s population. The purpose of this research study is to test the safety of an experimental vaccine, called PfSPZ Vaccine. We will also be studying whether or not the vaccine can prevent malaria.
You can read more about the study at ClinicalTrials.gov.
Healthy adults between 18 and 45 years of age may be eligible to participate in this study.
Volunteers are screened with a physical exam, medical history, and blood tests. There are 5 different groups in the study. Follow-up may last between 12 and 52 weeks, depending upon the group.
The NIH Clinical Center in Bethesda, Maryland. The NIH campus is accessible by car and public transportation.
You will be compensated for your participation in the study.
For more information on VRC 312 (ClinicalTrials.gov Identifier: NCT01441167), call toll-free 1-866-833-5433, or email email@example.com.
Last Updated March 28, 2012